Ribi ImmunoChem Research, Inc.
Patent Owner
Stats
- 5 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Nov 20, 2003 most recent publication
Details
- 5 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,262 Total Citation Count
- May 26, 1982 Earliest Filing
- 22 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6355257 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectorsMay 07, 98Mar 12, 02[A61K, C07H]
6113918 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectorsMay 08, 97Sep 05, 00[A61K, C07H]
5762943 Methods of treating type I hypersensitivity using monophosphoryl lipid AMay 14, 96Jun 09, 98[A61K]
5286718 Method and composition for ameliorating tissue damage due to ischemia and reperfusionDec 31, 91Feb 15, 94[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
4912094 Modified lipopolysaccharides and process of preparationExpiredJun 29, 88Mar 27, 90[C07H, C07G, C12P]
4844894 Method of inhibiting the onset of septicemia and endotoxemiaExpiredNov 25, 86Jul 04, 89[A61K]
4803070 Immunological emulsion adjuvants for polysaccharide vaccinesExpiredApr 15, 86Feb 07, 89[A61K]
4663306 Pyridine-soluble extract-refined detoxified endotoxin composition and useExpiredSep 23, 83May 05, 87[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.